Ticker Details
Arcellx, Inc. Common Stock
IPO Date:	February 4, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.71B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.16 | 2.59%
Avg Daily Range (30 D):	$0.08 | 0.07%
Avg Daily Range (90 D):	$0.90 | 1.30%

Institutional Daily Volume
Avg Daily Volume:	.53M
Avg Daily Volume (30 D):	1.43M
Avg Daily Volume (90 D):	1.64M

Trade Size
Avg Trade Size (Sh.):	59
Avg Trade Size (Sh.) (30 D):	88
Avg Trade Size (Sh.) (90 D):	91

Institutional Trades
Total Institutional Trades:	2,825
Avg Institutional Trade:	$3.75M
Avg Institutional Trade (30 D):	$10.1M
Avg Institutional Trade (90 D):	$7.29M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$5.15M
Avg Closing Trade (30 D):	$21.34M
Avg Closing Trade (90 D):	$13.7M
Avg Closing Volume:	86.76K

News

Apr 7, 2026 @ 4:06 PM Gilead Acquisition Spree Continues With $3 Billion... Source: Vandana Singh

Mar 24, 2026 @ 5:58 PM Gilead Powers Up Its Inflammation Pipeline With Ov... Source: Vandana Singh

Mar 16, 2026 @ 11:13 PM This $64 Million Biotech Exit Seemingly Missed a 7... Source: Jonathan Ponciano

Mar 4, 2026 @ 7:46 PM Halper Sadeh LLC is Investigating Whether ACLX, VR... Source: Halper Sadeh Llc

Feb 25, 2026 @ 3:09 PM Gilead Snaps Up Arcellx For $115 Per Share â€â€... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-4.07	$-1.01	$-4.07
Diluted EPS	$-4.07	$-1.01	$-4.07
Revenue	$22.29M	$1.65M	$22.29M
Gross Profit
Net Income / Loss	$-228.93M	$-58.11M	$-228.93M
Operating Income / Loss	$-253.08M	$-63.68M	$-253.08M
Cost of Revenue
Net Cash Flow	$-25.43M	$1.26M	$-25.43M
PE Ratio